info@science-fund.kz   +7 7172 76 85 74

Automation of Diabetic Retinopathy Screening Using Artificial Intelligence Technology

Project number 0094-18
Project name Automation of Diabetic Retinopathy Screening Using Artificial Intelligence Technology
Applicant LLP “Eye lab”
Grantee LLP “Eye lab”
Private partner
Term of realization 2018-2022
Place of implementation (city/region) Almaty
Industry Healthcare
Project Objective Development and commercialization of a cloud-based software solution for automation of diabetic retinopathy screening using artificial intelligence algorithms
Project description Developed a system to automate diabetic retinopathy screening using artificial intelligence technology;
Commercial launch of diabetic retinopathy screening services; Contracting with medical institutions or local executive bodies.
Website https://dr.eyelab.kz/
List of sold products with indication of price Recognition of DR as SaaS 1 survey – 1 000 tg., Bronze license 1000 surveys per year – 800 000 tg., Silver license 1500 surveys per year – 1 000 000 tg., Gold license Unlimited within one year – 1 500 000 tg.
Project team (full name) Urikh K.A., Zhanilbekuly E., Abilmagzhanova J.K., Aymyshev T.T., Eszhanova A.A., Esekeev D.M., Bayzakov T.T.
Indicators Sales – 20 069 400,00 / Royalties – 100 000 / Jobs – 7 / Taxes – 733 479,00